Show Notes
In this week's episode, we see what science says about omega-3 and depression. Does omega-3 help manage symptoms of depression? What kind of omega-3 are we talking about? What is the optimal dose? Listen to find out the answer to these questions and more! Mahshad, our host, is a neuroscientist and PhD candidate that will answer these questions based on data from peer-reviewed articles from reputable sources.
References: Liao et al., Efficacy of omega-3 PUFAs in depression: A meta-analysis, Translational Psychiatry (2019)9:190 Nemets at l., Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder, Am J Psychiatry 2002; 159:477–479) Peet et al., A Dose Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients with Ongoing Depression Despite Apparently Adequate Treatment with Standard Drugs, Arch Gen Psychiatry 2002
More from What Science Says
In today's episode, we learn the conditions we need to meet for our brain to undergo neuroplasticity in adulthood. We learn easy and neuroscience-proven skills that we can incorporate in our day to day to set ourselves up for success for learning and aging.
In this episode, Mahshad goes over the history and basics of neuroplasticity. We learn about the two different types of neuroplasticity and lay the foundation for future episodes on how to access neuroplasticity in adulthood.
In this episode of the What Science Says Podcast, we learn about how probiotics can help manage the symptoms of autism by helping manage gastrointestinal symptoms and potentially changing brain activity patterns.
In this episode, we are going to talk about the critical time periods that gut dysbiosis that increase the development of autism. We will end with 10 ways to take care gut microbiome of the child both in and out of the womb, to help reduce the risk of autism development.
Hello and welcome to this week’s episode of the What Science Says Podcast. In today’s episode, we talk about how gut dysbiosis can significantly increase the risk of autism, by impairing brain development in critical early years of life.